RVMD insider trades & Congress trades
Revolution Medicines, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 80 open-market insider transactions in Revolution Medicines, Inc. (RVMD) (0 purchases with code P and 80 sales with code S), the most recent on October 26, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 80 sales by 9 ($78.4M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Mancini Anthony | See Remarks | Sell | 2,310 | $186.99 | $432K | – |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 2,200 | $200.82 | $442K | −0.1% |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 1,609 | $201.72 | $325K | −0.1% |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 1,000 | $202.81 | $203K | −0.1% |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 1,199 | $203.91 | $244K | −0.1% |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 301 | $204.72 | $62K | −0.1% |
| Sep 25, 2026 | Mancini Anthony | See Remarks | Sell | 3,121 | $200.54 | $626K | −0.1% |
| Sep 25, 2026 | Cislini Jeff | SVP & General Counsel | Sell | 765 | $207.32 | $159K | −0.1% |
| Sep 24, 2026 | Mancini Anthony | See Remarks | Sell | 587 | $200.00 | $117K | −0.1% |
| Sep 22, 2026 | Anderson Elizabeth M | – | Sell | 910 | $191.85 | $175K | −0.1% |
| Sep 22, 2026 | Anderson Elizabeth M | – | Sell | 4,985 | $192.54 | $960K | −0.1% |
| Sep 22, 2026 | Anderson Elizabeth M | – | Sell | 2,648 | $193.44 | $512K | −0.1% |
| Sep 22, 2026 | Anderson Elizabeth M | – | Sell | 1,500 | $194.59 | $292K | −0.1% |
| Sep 22, 2026 | Anderson Elizabeth M | – | Sell | 100 | $195.15 | $20K | −0.1% |
| Sep 18, 2026 | Mancini Anthony | See Remarks | Sell | 1,764 | $196.94 | $347K | +0.0% |
| Sep 16, 2026 | Anders Jack | Chief Financial Officer | Sell | 61 | $195.00 | $12K | −0.0% |
| Sep 16, 2026 | Anders Jack | Chief Financial Officer | Sell | 3,992 | $199.30 | $796K | −0.0% |
| Sep 16, 2026 | Cislini Jeff | SVP & General Counsel | Sell | 52 | $195.01 | $10K | −0.0% |
| Sep 16, 2026 | Cislini Jeff | SVP & General Counsel | Sell | 3,314 | $199.30 | $660K | −0.0% |
| Sep 16, 2026 | Goldsmith Mark A | See Remarks | Sell | 213 | $195.01 | $42K | −0.0% |
| Sep 16, 2026 | Goldsmith Mark A | See Remarks | Sell | 13,775 | $199.30 | $2.75M | −0.0% |
| Sep 16, 2026 | Horn Margaret A | Chief Operating Officer | Sell | 76 | $195.01 | $15K | −0.0% |
| Sep 16, 2026 | Horn Margaret A | Chief Operating Officer | Sell | 4,891 | $199.30 | $975K | −0.0% |
| Sep 16, 2026 | Mancini Anthony | See Remarks | Sell | 27 | $195.05 | $5K | −0.0% |
| Sep 16, 2026 | Mancini Anthony | See Remarks | Sell | 1,747 | $199.30 | $348K | −0.0% |
| Sep 16, 2026 | Kelsey Stephen Michael | See Remarks | Sell | 85 | $195.01 | $17K | −0.0% |
| Sep 16, 2026 | Kelsey Stephen Michael | See Remarks | Sell | 5,484 | $199.30 | $1.09M | −0.0% |
| Sep 16, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 5 | $194.96 | $975 | −0.0% |
| Sep 16, 2026 | Sandler Alan B. | Chief Development Officer | Sell | 336 | $199.30 | $67K | −0.0% |
| Sep 11, 2026 | Kelsey Stephen Michael | See Remarks | Sell | 800 | $198.55 | $159K | −0.0% |
Showing the 30 most recent of 80 transactions.
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.